Acral Lentiginous Melanoma - 12 Studies Found
| Recruiting |
: Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma : Acral Lentiginous Melanoma : 2016-08-07 : Drug: pembrolizumab pembrolizumab at 200mg IV infusion every 3 weeks |
| Not yet recruiting |
: A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab :
: 2016-11-23 :
|
| Not yet recruiting |
: A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread :
|
| Completed |
: SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma :
|
| Active, not recruiting |
: Dinaciclib in Treating Patients With Stage IV Melanoma :
: Drug: Dinaciclib Given IV Other Names: |
| Completed |
: Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery :
: |
| Terminated |
: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma :
|
| Completed |
: AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma :
|
| Terminated |
: Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma : Melanoma : 2010-03-23 :
|
| Completed |
: Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma : Melanoma (Skin) : 2000-04-06 :
|